CNBX Pharmaceuticals Inc. (CNBX) stock
CNBXOTCPharmaceutical PreparationsFiscal year ends August 31
$0.00+0.00 (0.00%)
Close on Oct 19, 2026Market cap $197.79KP/E –Yield –
CNBX Pharmaceuticals enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
CNBX Pharmaceuticals's enterprise value was $331.88K on Oct 19, 2026, against $206.47K a year earlier. Over the last 5 years it ranged from -$54.12K to $2.36B, with a median of $219.36K.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Oct 19, 2026 | $331.88K | +60.7% |
| 2025 | Dec 31, 2025 | $206.47K | +1.3% |
| 2024 | Dec 31, 2024 | $203.81K | +6.5% |
| 2023 | Dec 29, 2023 | $191.39K | -91.2% |
| 2022 | Dec 30, 2022 | $2.19M | -99.8% |
| 2021 | Dec 31, 2021 | $1.40B | -58.5% |
| 2020 | Dec 31, 2020 | $3.38B | +71.1% |
| 2019 | Dec 31, 2019 | $1.97B | -53.4% |
| 2018 | Dec 31, 2018 | $4.23B | -83.7% |
| 2017 | Dec 29, 2017 | $25.96B | +194.8% |
| 2016 | Dec 30, 2016 | $8.81B | +1226.8% |
| 2015 | Dec 31, 2015 | $663.84M | -80.3% |
| 2014 | Dec 31, 2014 | $3.37B | +58850.7% |
| 2013 | Dec 31, 2013 | $5.71M | -58.8% |
| 2012 | Dec 31, 2012 | $13.88M | – |
See a number that looks wrong?